NCT01571401 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Trinh L, Plotnikoff RC, Rhodes RE, North S, Courneya KS
Associations between physical activity and quality of life in a population-based sample of kidney cancer survivors. Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):859-68. doi: 10.1158/1055-9965.EPI-10-1319. Epub 2011 Apr 5.
Trinh L, Plotnikoff RC, Rhodes RE, North S, Courneya KS
Physical activity preferences in a population-based sample of kidney cancer survivors. Support Care Cancer. 2012 Aug;20(8):1709-17. doi: 10.1007/s00520-011-1264-z. Epub 2011 Sep 24.

Trying Activity in Kidney Cancer Survivors (TRACKS) Trial: A Randomized Controlled Trial Comparing the Effects of Supervised Physical Activity Versus Supervised Physical Activity Plus Behavioural Counselling

Details for clinical trial NCT01571401

Clinical trial NCT01571401 - References